Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.

被引：0
|
作者：
Boumelha, Jesse [1 ]
de Carne, Sophie [1 ]
Mugarza, Edurne [1 ]
Romero-Clavijo, Pablo [1 ]
Molina-Arcas, Miriam [1 ]
Downward, Julian [1 ]
机构：
[1] Francis Crick Inst, London, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1820
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer
    Boumelha, Jesse
    de Carne, Sophie
    Romero, Pablo
    Moliona, Miriam
    Downward, Julian
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [2] In vivo CRISPR screening identifies mediators of immune evasion in KRAS-mutant lung cancer
    Boumelha, Jesse
    Romero-Clavijo, Pablo
    de Carne, Sophie
    Molina-Arcas, Miriam
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Immunogenic chemotherapy effectively constrains KRAS-mutant lung cancer
    Wang, D.
    Cong, J.
    Fu, B.
    Zheng, X.
    Sun, R.
    Tian, Z.
    Wei, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1893 - 1893
  • [4] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [5] A novel combination strategy to treat KRAS-mutant lung cancer
    Peng, R. -W.
    Liang, S. -Q.
    Buhrer, E. D.
    Berezowska, S.
    Marti, T. M.
    Froment, L.
    Yang, H.
    Hall, S. R.
    Vassella, E.
    Yang, Z.
    Kocher, G. J.
    Amrein, M. J.
    Riether, C.
    Ochsenbein, A. F.
    Schmid, R. A.
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 19 - 19
  • [6] Mechanims of Immune Evasion in Patients With KRAS-Mutant Lung Adenocarcinoma: A Role of MAPK Pathway Activation
    Naves, D.
    Van Ee, T. J.
    Van Maldegem, F.
    De Gruijl, T. D.
    Van Kooyk, Y.
    Radonic, T.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S84 - S85
  • [7] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [8] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [9] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [10] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
12345